Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

PaperCitations, authors & open-access status

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 585 citations, 2006 year and closed oa status.

585
Citations
2006
Year
closed
OA Status

Related on ScholarIQ

Lecia V. Sequist
Author
Balázs Halmos
Author
Pasi A. Jänne
Author
Clinical Cancer Research
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account